Amphastar Pharmaceuticals (29A.F) Q4 2024 Earnings

Nov 6Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
0.71
0.79
0.88
0.97

Details

Expected EPS
0.90671724
Actual EPS
0.8810208
Surprise EPS
-0.03
Surprise Percent
-2.83%

Description

⁨Amphastar Pharmaceuticals⁩ (⁦29A.F⁩) has reported earnings of ⁦0.8810208⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts